PRS34 Cost-Effectiveness of Roflumilast (DAXAS®) in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) in Spain
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1421
https://www.valueinhealthjournal.com/article/S1098-3015(11)02983-4/fulltext
Title :
PRS34 Cost-Effectiveness of Roflumilast (DAXAS®) in the Treatment Of Chronic Obstructive Pulmonary Disease (COPD) in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02983-4&doi=10.1016/j.jval.2011.08.1421
First page :
A493
Section Title :
Respiratory-Related Disorders
Open access? :
No
Section Order :
1372